We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Price loading...
Horizons in Cancer Research. Volume 73: Volume 73
Price data last checked 104 day(s) ago - refreshing...
Price History & Forecast
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Description
In Horizons in Cancer Research. Volume 73, after the identification of some small subgroups with a strong biological-molecular identity, the current evidence regarding the prognostic factors of patients with non-eradicable metastatic disease are examined. The goal is to discuss disease subgroups, which may sometimes provide conditions for decisions that are less compliant with current clinical practice and help define new stratification criteria for patients enrolled in prospective studies. Following this, the authors summarize the current knowledge on breast cancer with an introduction on the traditional markers used in the diagnosis of this disease, followed by an account of the emerging markers. Next, the underlying mechanisms of DNA replication, damage and repair are discussed. Further, RAD51 is proposed as a potential means of managing chemoresistant cancers. Certain drugs and strategies can sensitize chemotherapy via impacting on RAD51, which can be developed as chemotherapy modulators. The authors also discuss multiple myeloma, an incurable malignant tumor of plasma cells of the bone marrow, which is the most common primary neoplasm arising in bone. It causes approximately 1% of cancer-related deaths and is the 2nd most common hematological malignancy in the western world. Later, this collection discusses the prevalence and types of infectious complications that patients with multiple myeloma face, as well as present and emerging therapeutic approaches. The concluding study indicates proteins that have a promising future as new anticancer drugs, in conjunction with the in vitro and/or in vivo effects of these bioactive proteins derived from plants.
Product Specifications
- Format
- hardcover
- ASIN
- 1536162736
- Domain
- Amazon UK
- Release Date
- 15 October 2019
- Listed Since
- 18 July 2019
Barcode
No barcode data available
Similar Products You Might Like
95% match
Horizons in Cancer Research: Volume 71
£114.26
09 Dec 2025
94% match
Horisons in Cancer Research: Volume 61 - Nova Science Publishers
£88.19
07 Mar 2026
94% match
Horizons in Cancer Research: Volume 69 (Horizons in Cancer Research)
£188.60
14 Jan 2026
94% match
Horizons in Cancer Research: Volume 68
£192.74
08 Jan 2026
94% match
Bone Cancer: Progression and Therapeutic Approaches
Academic Press
£69.84
24 Feb 2026
94% match
Multiple Myeloma: Translational and Emerging Therapies (Translational Medicine)
CRC Press
£81.99
01 Mar 2026
93% match
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
Springer
£84.29
08 Mar 2026
93% match
Hematologic Malignancies: An Overview - Hematology Research
Out of Stock
17 Apr 2026
93% match
Springer - Advances in Biology and Therapy of Multiple Myeloma 2
Springer
£107.43
01 Mar 2026
93% match
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
Springer
£103.09
06 Jan 2026
93% match
Advances in Cancer Research: 79: Volume 79 (Advances in Cancer Research, Volume 79)
Academic Press
£98.99
07 Jan 2026
93% match
Bone Cancer: Primary Bone Cancers and Bone Metastases
Academic Press
£102.19
25 Feb 2026
93% match
Breast Cancer Metastasis and Drug Resistance: Challenges and Progress: 1152 (Advances in Experimental Medicine and Biology, 1152)
Springer
£148.75
08 Mar 2026
93% match
Hematopoietic Growth Factors in Oncology: 157 (Cancer Treatment and Research, 157)
Springer
£155.05
18 Mar 2026
93% match
Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside
Academic Press
£166.49
25 Jan 2026
93% match
Tissue Stiffness as a Risk of Cancer Development and Impact on Clinical Outcome in Solid Tumors: A Systematic Review (Cancer Etiology, Diagnosis and Treatments)
£203.99
10 Mar 2026
93% match
Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)
Humana
£147.91
10 Mar 2026
93% match
Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)
Humana
£117.40
15 Jan 2026
93% match
Plant Flavonoids Against Metastasis: New Concepts For Cancer Treatment (Cancer Etiology, Diagnosis and Treatments)
£179.24
15 Jan 2026
93% match
Genomic Instability and Cancer Metastasis: Mechanisms, Emerging Themes, and Novel Therapeutic Strategies: 20 (Cancer Metastasis - Biology and Treatment, 20)
Springer
£75.84
01 Mar 2026
93% match
HORIZONS IN CANCER RES.V.51: Volume 51 (Horizons in Cancer Research)
Brand: Nova Science Pub Inc
£12.66
10 Mar 2026
93% match
Brain Metastases from Primary Tumors, Volume 3: Epidemiology, Biology, and Therapy of Melanoma and Other Cancers
Academic Press
£61.07
26 Feb 2026
93% match
Myeloma Bone Disease (Current Clinical Oncology)
Humana
£139.86
21 Feb 2026
92% match
Handbook of Tumor Syndromes
CRC Press
£196.55
06 Feb 2026